Hippo Labs Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24230TG1997PTC026912 Incorporated 21 April 1997 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2024
₹7.55 Cr
▼ 2% YoY
Net profit · FY 2024
₹80,321
Net margin 0.1%
EBITDA · FY 2024
₹24.72 Lakh
EBITDA margin 3.3%
Authorised capital
₹65 Lakh
Registered with MCA
Paid-up capital
₹21.82 Lakh
Issued & subscribed
Open charges
₹2.92 Cr
Satisfied ₹10 Lakh
Company age
29 yrs
Est. 1997
Employees · EPFO
10
Provident fund records

About Hippo Labs Private Limited

Data last updated:

Hippo Labs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 April 1997 and has been in existence for over 29 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG1997PTC026912. Its GSTIN is 36AABCH7710A1Z4 (Telangana). The company holds 4 GST registrations, of which 3 are active.

The company has an authorised share capital of ₹65 Lakh and a paid-up capital of ₹21.82 Lakh. It is led by directors Patibandla Malyadri (Managing Director) and Dhana Lakshmi Patibandla.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Flat No.17 Rajiv Gandhi Nagar Kukatpally Industrial Estate Kukatpally, Hyderabad, Telangana, India – 500072.

As per the financials filed for FY 2024, the company reported a revenue of ₹7.55 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹80,321 (net margin 0.1%) and EBITDA of ₹24.72 Lakh (EBITDA margin 3.3%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 2% over five years.

The company has about 10 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹2.92 Cr and satisfied charges of ₹10 Lakh on record. Court records list 4 cases involving the company, including 4 filed against it; 2 cases are pending.

Hippo Labs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0024451). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hippolabs.in.

Company details

CIN U24230TG1997PTC026912
Registration Number 026912
Incorporation Date 21 April 1997
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0024451

CIN history

Hippo Labs has one previous CIN (Corporate Identification Number): U24230AP1997PTC026912. The current CIN is U24230TG1997PTC026912, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24230TG1997PTC026912Current
U24230AP1997PTC026912Previous

Recognitions & Rankings of Hippo Labs

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-TS-20-0024451

Contact details

Hippo Labs Private Limited's registered office is in Hyderabad, Telangana. Its website is hippolabs.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Flat No.17 Rajiv Gandhi Nagar Kukatpally Industrial Estate Kukatpally, Hyderabad, Telangana, India – 500072
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Hippo Labs Private Limited, buy the company report.

Comprehensive company report
Hippo Labs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Hippo Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Hippo Labs Private Limited, buy the company report.

Financials of Hippo Labs Private Limited

FY 2024 filings available

Hippo Labs Private Limited reported revenue of ₹7.55 Cr (down 2% YoY) for FY 2024.

Revenue · FY 2024
₹7.55 Cr ▼ 2%
Net profit · FY 2024
₹80,321 margin 0.1%
EBITDA · FY 2024
₹24.72 Lakh margin 3.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 1%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▼ 23%
3 years · compounded
▼ 7%
5 years · compounded
▼ 2%

Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 2% fall in the latest year. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹24.72 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹80,321
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin3.3%
Net Profit Margin0.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Hippo Labs Private Limited, buy the company report.

Board of directors of Hippo Labs Private Limited

Hippo Labs has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Patibandla MalyadriManaging Director09 Jul 200818 Years 3 MonthsCurrent
Dhana Lakshmi PatibandlaDirector19 Nov 201411 Years 11 MonthsCurrent

Peer comparison

Hippo Labs Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Asphar Research Labs Private Limited₹7.57 Cr (FY 2025)19.0%Hyderabad, Telangana, India
Visvas Lifesciences Private Limited₹7.56 Cr (FY 2021)1489.0%Hyderabad, Telangana, India
Q P Pharmachem Limited₹7.55 Cr (FY 2025)-36.0%Chandigarh, India
Hippo Labs Private Limitedthis company₹7.55 Cr (FY 2024)₹80,3210.1%-2.0%10Hyderabad, Telangana, India

To see the full peer comparison of Hippo Labs Private Limited, buy the company report.

Auditor

Hippo Labs Private Limited is audited by SPC and Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
SPC and AssociatesFY 2023005685S

Shareholding

The shareholding of Hippo Labs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Hippo Labs Private Limited, buy the company report.

Charges & borrowings

Open charges
₹2.92 Cr
Satisfied charges
₹10 Lakh
Breakdown by lending institutions
Canara Bank₹2.47 Cr
Others₹0.45 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
07 Apr 2020100335754Others₹45 LakhOpen
30 Mar 201510565025Canara Bank₹2.47 CrOpen
08 Oct 200910185277The Karur Vysya Bank Limited₹3 LakhSatisfied
19 Jul 200810115013The Karur Vysya Bank Ltd₹7 LakhSatisfied

To see the full charge records of Hippo Labs Private Limited, buy the company report.

Total charge records: 4 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Hippo Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Hippo Labs Private Limited has a workforce of 10 employees on its EPFO records as of Feb 03, 2025, across 1 active EPFO establishment.

Employee count
10
Active EPFO establishments
1
Employee growth
-9.09%

GST

Hippo Labs has 4 GST registrations: 3 active and 1 cancelled or inactive.

Total GSTINs
4
Active
3
Cancelled / inactive
1
GSTINStateStatusRegistered on
36AABCH7710A1Z4TelanganaActive01 Jul 2017
36AADCH8655G2ZBTelanganaActive30 Aug 2017
37AABCH7710A1Z2Andhra PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Hippo Labs Private Limited, buy the company report.

Recent activity

Hippo Labs Private Limited has 9 board changes on record since 2008: 2 appointments and 7 cessations. The latest: Dhana Lakshmi Patibandla ceased to be Additional Director on 30 Sep 2017.

AGM
Hippo Labs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Hippo Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Canara Bank of Rs. 246.60 Lakh registered on 30 Mar 2015 with Charge ID 10565025 was modified on 10 Nov 2021.
Charges
A charge with Others amounted to Rs. 45.00 Lakh with Charge ID 100335754 was registered on 07 Apr 2020.
Ceased
Dhana Lakshmi Patibandla ceased to be Additional Director.
Charges
A charge with Canara Bank amounted to Rs. 246.60 Lakh with Charge ID 10565025 was registered on 30 Mar 2015.
Charges
A charge registered on 08 Oct 2009 via Charge ID 10185277 with The Karur Vysya Bank Limited was fully satisfied on 24 Mar 2015.
Charges
A charge registered on 19 Jul 2008 via Charge ID 10115013 with The Karur Vysya Bank Ltd was fully satisfied on 24 Mar 2015.
Appointed
Dhana Lakshmi Patibandla was appointed as Director.
Ceased
Venkata Srikanth Dasigi ceased to be Director.
Ceased
Patibandla Malyadri ceased to be Director.
Charges
A charge with The Karur Vysya Bank Limited amounted to Rs. 3.00 Lakh with Charge ID 10185277 was registered on 08 Oct 2009.

7 earlier events are in the company report.

Frequently asked questions

Hippo Labs is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 April 1997 (29+ years old) and is registered under CIN U24230TG1997PTC026912.

Hippo Labs has 2 current directors:

The latest financial statements of Hippo Labs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Hippo Labs is 36AABCH7710A1Z4, registered in Telangana. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 36AADCH8655G2ZB (Telangana), 37AABCH7710A1Z2 (Andhra Pradesh).

The CIN (Corporate Identification Number) of Hippo Labs is U24230TG1997PTC026912. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Hippo Labs has 4 court cases on record: 4 filed against it. 2 are pending.

Hippo Labs was incorporated on 21 April 1997, making it 29+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Hippo Labs by revenue are Asphar Research Labs Private Limited, Visvas Lifesciences Private Limited, Q P Pharmachem Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Dhana Lakshmi Patibandla ceased to be Additional Director on 30 Sep 2017. Dhana Lakshmi Patibandla was appointed as Director on 19 Nov 2014. Venkata Srikanth Dasigi ceased to be Director on 19 Nov 2014. Hippo Labs has 9 board changes on record in total.

Yes, Hippo Labs is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0024451).

Hippo Labs can be reached through the website hippolabs.in. Its registered office is in Hyderabad, Telangana, India.